119162-50-4 Usage
Uses
Used in Medicinal Chemistry:
5-Amino-3-(3-fluorophenyl)isoxazole serves as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with specific therapeutic targets, potentially leading to the creation of novel treatments for a range of diseases.
Used in Agrochemicals:
In the agrochemical industry, 5-Amino-3-(3-fluorophenyl)isoxazole is utilized as a precursor for the synthesis of bioactive compounds. These compounds can be used in the development of pesticides, herbicides, and other agricultural chemicals, contributing to more effective and targeted crop protection strategies.
Used as a Ligand in Coordination Chemistry:
5-Amino-3-(3-fluorophenyl)isoxazole's structural features make it a suitable candidate for use as a ligand in coordination chemistry. It can form stable complexes with various metal ions, which can be employed in a wide range of applications, such as catalysts for chemical reactions, sensors, and materials with unique electronic or magnetic properties.
Used in Catalysis:
5-AMino-3-(3-fluorophenyl)isoxazole's ability to form complexes with metal ions also makes it a promising catalyst in various chemical reactions. Its use in catalysis can lead to more efficient and selective processes, reducing the environmental impact and improving the overall sustainability of chemical production.
Check Digit Verification of cas no
The CAS Registry Mumber 119162-50-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,9,1,6 and 2 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 119162-50:
(8*1)+(7*1)+(6*9)+(5*1)+(4*6)+(3*2)+(2*5)+(1*0)=114
114 % 10 = 4
So 119162-50-4 is a valid CAS Registry Number.
119162-50-4Relevant academic research and scientific papers
WNT PATHWAY MODULATORS
-
Paragraph 0197; 0198; 0217; 0218, (2015/07/07)
The present invention relates to dihydropyrazolo[l,5-a]pyrimidine compounds of formula I, defined herein, as WNT pathways modulators, processes for making them, and pharmaceutical compositions comprising them. Methods of treatment of conditions mediated by WNT pathway signalling including cancer, fibrosis, stem cell and diabetic retinopathy, rheumatoid arthritis, psoriasis and myocardial infarction, comprising the compounds of formula I are also provided.
